Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
mice
100%
hypertrophy
89%
diseases
78%
rna
75%
heart failure
74%
proteins
68%
genes
60%
humans
52%
patients
44%
muscles
38%
levels
36%
myocardium
30%
in vivo
29%
comparative evaluations
29%
ischemia
28%
regeneration
27%
reviews
26%
cardiovascular diseases
24%
apoptosis
24%
adults
24%
tissues
24%
delivery
24%
kinases
23%
genetics
23%
biological markers
23%
stem cells
23%
animals
22%
therapy
22%
control
22%
in vitro
21%
receptors
21%
molecules
20%
biology
20%
capacity
20%
transcription factors
20%
phenotype
20%
death
20%
aging
19%
regulations
18%
myocardial infarction
18%
injuries
17%
mutations
15%
drugs
15%
interactions
14%
modeling
14%
oxidation
14%
proliferation
14%
organs
14%
doses
14%
heart disease
13%
inflammation
12%
inhibition
12%
barriers
12%
losses
12%
applications
11%
data
11%
modifications
11%
mitochondria
11%
fibroblasts
11%
failures
11%
cargo
10%
transgenic mice
10%
interventions
10%
screening
10%
growth
10%
matrices
10%
fibrosis
10%
walls
10%
mortality
10%
risks
9%
angiogenesis
9%
arteries
9%
dna
9%
volume
9%
pathogenesis
9%
nucleotides
9%
transport
9%
investigations
9%
surgery
8%
tools
8%
balances
8%
modulation
8%
stimuli
8%
cardiovascular system
8%
values
8%
peptides
8%
chromatin
8%
pregnancy
8%
mutants
8%
cyclases
8%
metabolism
8%
reduction
7%
populations
7%
loading
7%
administration
7%
placenta
7%
promoters
7%
information
7%
artificial intelligence
7%
spectra
7%
Keyphrases
MicroRNA
55%
Cardiomyocytes
45%
Heart Failure
43%
Non-coding RNA (ncRNA)
42%
Arrhythmogenic Cardiomyopathy
31%
Extracellular Vesicles
31%
Induced Pluripotent Stem Cells (iPSCs)
21%
On-a-chip
21%
Cardiovascular Disease
20%
Endothelial Cells
16%
Cardiac Hypertrophy
15%
Cardiac Regeneration
15%
Hypertrophy
13%
Cardiac Disease
13%
Cardiac Function
13%
Myocardium
11%
Cardiac Development
11%
Aging
11%
Aortic Stenosis
10%
Cellular Biology
10%
Cardiac Cells
10%
Pressure Overload
9%
Pathogenic Variants
9%
Oxidative Stress
9%
Cardiac muscle
8%
Cardiovascular Research
8%
Cardiomyocyte Proliferation
8%
Large Animal Model
8%
Transcriptome
8%
Epigenetics
7%
Cardiovascular System
7%
Pathophysiology
7%
Transcription Factor
7%
Metabolic Alterations
7%
MiR-200c-3p
7%
Angiogenic Capacity
7%
Circulating miRs
7%
Transcriptomics
7%
Artificial Intelligence
7%
Hyperplasia
7%
Scientific Statement
7%
Mouse Model
6%
Therapeutic Target
6%
Cardiac Remodeling
6%
Molecular Mechanism
6%
Placenta
6%
Human Heart
6%
Intercellular Communication
6%
Murine Model
5%
Cardiovascular Therapy
5%
Myocardial Infarction
5%
Contractile Cell
5%
Energy Metabolism
5%
RNA Sequencing (RNA-seq)
5%
Apoptosis
5%
Extracellular Matrix
5%
Small Extracellular Vesicles
5%
Cellular Mechanisms
5%
MiR-199a-3p
5%
Natural Aging
5%
Inherited Cardiomyopathy
5%
Cell-based
5%
Therapeutic Strategies
5%
Long Non-coding RNA (LncRNA)
5%
TP63
5%
Exosomes
5%
Biochemistry, Genetics and Molecular Biology
Cardiac Muscle Cell
73%
MicroRNA
51%
Calcineurin
34%
Heart Function
26%
Human Induced Pluripotent Stem Cell
23%
RNA
16%
Non-Coding RNA
15%
Mouse Model
15%
Programmed Cell Death
15%
Genetics
15%
Animal Model
14%
Long Non-Coding RNA
13%
Oxidative Stress
11%
Cardiac Dysrhythmia
9%
Signal Transduction
9%
Downregulation
9%
Heart Ejection Fraction
9%
Transcription Factors
8%
Transgenics
8%
Cell Communication
8%
Induced Pluripotent Stem Cell
8%
DNA Repair
8%
Transcriptome
8%
Knockout Mouse
7%
Transcription Factor NFAT
7%
Reperfusion
7%
Murine
7%
Transgenic Mouse
7%
Epigenomics
7%
Epigenetics
7%
Phospholipase A2
7%
Blood Placenta Barrier
7%
Transcriptomics
7%
TP63
7%
Progeria
6%
Desmoglein-2
6%
Desmoplakin
6%
Mediator
6%
Hemodynamic
5%
Mouse Mutant
5%
Cell Death
5%
Antagomir
5%
Lifespan
5%
Gene Expression
5%
Genetic Disorder
5%